Cariprazine is a medicine used to treat schizophrenia, bipolar disorder and depression. It's taken as a capsule once a day. It works by balancing brain chemicals called dopamine and serotonin.
Every report comes from a Lived member, sent anonymously.
Have you tried Vraylar (Cariprazine) for Bipolar Disorder?
Cariprazine, sold under the brand name Vraylar, is a prescription medicine from the group called atypical antipsychotics. It is approved in the US for four uses. It treats schizophrenia in adults and teenagers 13 and older. It treats manic or mixed episodes of bipolar I disorder in adults and children 10 and older. It treats the depressive episodes of bipolar I disorder (bipolar depression) in adults. And it can be added to an antidepressant for adults with major depressive disorder whose symptoms have not improved enough on the antidepressant alone. That last use is different from the others: cariprazine is not meant to replace the antidepressant, but to work alongside it. It is not approved to treat agitation or psychosis caused by dementia in older adults.
Dopamine and serotonin are chemical messengers that help regulate mood, motivation and how the brain sorts out what is real and important. In schizophrenia and in the manic phase of bipolar disorder, some dopamine pathways appear to be overactive, while in depression signaling in other circuits may be too weak. Cariprazine is a partial agonist at dopamine receptors: it switches a receptor on, but only part of the way. Where dopamine signaling is excessive, it occupies the receptor and dampens the signal; where signaling is low, it provides some activity of its own. It acts in a similar way on one type of serotonin receptor and blocks another. It binds especially strongly to the D3 dopamine receptor, which sets it apart from many related medicines, although how much that matters for its benefits is not established. The FDA label notes that the exact reason it helps is not fully understood. The body converts cariprazine into active breakdown products, one of which lasts for weeks. That long staying power shapes how dose changes, side effects and stopping play out.
Cariprazine is a capsule taken once a day, with or without food. It comes in several strengths. The prescriber usually starts with a low dose and raises it over days to weeks, depending on the condition, how well it works and how well it is tolerated. People taking it for bipolar depression or added to an antidepressant generally stay at lower doses than people taking it for schizophrenia or mania, and teenagers and children start lower than adults. Because the medicine builds up slowly, a dose change takes several weeks to have its full effect, so a prescriber will usually wait before adjusting again. Take it as prescribed and do not change the dose or stop on your own. Cariprazine can cause sleepiness and slow thinking or reaction time. Avoid driving or operating machinery until you know how it affects you. It can also make it harder for the body to cool down, so take care to avoid overheating and dehydration during hot weather or hard exercise.
The most common side effect is akathisia, an uncomfortable inner restlessness that makes it hard to sit still and can feel like a need to keep moving. Other movement-related effects, such as tremor, stiffness or slowed movements, are also common. Nausea, indigestion, constipation, sleepiness, trouble sleeping, dizziness, tiredness and increased appetite are other frequent complaints. Akathisia is worth reporting rather than enduring: it can be distressing, and a dose change or other adjustment often helps. Because cariprazine stays in the body for a long time, side effects, including akathisia, can first appear several weeks after starting or after a dose increase, not only in the first days. Tardive dyskinesia is a less common but important risk with this group of medicines: repetitive movements you cannot control, often of the face, lips or tongue. It may not go away even if the medicine is stopped, so new movements like these should be reported to the prescriber. Neuroleptic malignant syndrome is a rare, potentially life-threatening reaction. High fever, very stiff muscles, confusion, heavy sweating, or a racing heart or unstable blood pressure together call for contacting the prescriber right away or going to the emergency room. Like related medicines, cariprazine can raise blood sugar, change cholesterol and triglyceride levels and cause weight gain. Unusual thirst, needing to urinate much more than usual or unexplained weakness should be reported, since they can signal high blood sugar.
Cariprazine carries two boxed warnings, the FDA's most prominent kind. Older adults with dementia who are given antipsychotic medicines for psychosis have a higher risk of death, and cariprazine is not approved for that use. And, like antidepressants, it can increase suicidal thoughts and behaviors in children, teenagers and young adults up to age 24, especially in the first months and after dose changes. New or sudden changes in mood, behavior or thinking, including thoughts of suicide, worse depression or severe agitation, should be reported to the prescriber right away. Family members can help by watching for these changes. Cariprazine is broken down mainly by a liver enzyme called CYP3A4. Medicines that block this enzyme, such as the antifungal ketoconazole or the antibiotic erythromycin, raise the amount of cariprazine in the blood, so the prescriber will need to lower the dose. Medicines that speed up the enzyme are not recommended with it. Tell the prescriber and pharmacist about every prescription, over-the-counter medicine and supplement, and check before starting or stopping one. Anyone who is pregnant or planning a pregnancy should discuss it with the prescriber. Use late in pregnancy can cause movement or withdrawal symptoms in the newborn, and there is little human data on other effects. Because the active breakdown product can stay in the body for up to 12 weeks after the last dose, planning ahead matters. Whether it passes into breast milk is not known. People with a history of seizures, heart disease, stroke, diabetes, or low white blood cell counts should mention it, since these change how closely treatment is monitored. Anyone who has had an allergic reaction to cariprazine should not take it.
Improvement is gradual. In the studies that led to approval, benefits were measured after three to eight weeks, and because the medicine takes weeks to reach steady levels, both benefits and side effects can keep changing for a while after each dose change. In bipolar depression and when added to an antidepressant, the average improvement over placebo was real but modest, and some people respond much better than others. Before or soon after starting, the prescriber should check weight, blood sugar and cholesterol, and repeat these checks during long-term treatment. Follow-up visits are also a chance to look for restlessness, unusual movements and mood changes. In schizophrenia, a long-term trial found that adults who stayed on cariprazine after their symptoms had stabilized relapsed less often than those switched to a placebo, so treatment that works is often continued, with the need reassessed periodically. Stopping should be planned with the prescriber. Because the medicine leaves the body slowly, symptoms may not return right away after a missed dose or after stopping, which can make it harder to tell whether a change is working; a relapse can still appear weeks later.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Vraylar (Cariprazine), what you've noticed, or ask the community a question.